E-LIB Suche - Ergebnisse für: Persano, M.

1

184P Lenvatinib (L) versus sorafenib (S) second-line therap..:

Persano, M. ; Rimini, M. ; Foti, S....
Annals of Oncology. 35 (2024) - p. S83 , 2024

Link: https://doi.org/10.1016/..

2

182P A real-world, multicenter study of atezolizumab plus b..:

Rossari, F. ; Tada, T. ; Shimose, S....
Annals of Oncology. 35 (2024) - p. S82 , 2024

Link: https://doi.org/10.1016/..

3

Treatment of patients with BRAF-mutated metastatic colorect..:

Germani, M.M. ; Vetere, G. ; Santamaria, F....
ESMO Open. 9 (2024) 4 - p. 102996 , 2024

Link: https://doi.org/10.1016/..

4

93P The survival impact of the addition of durvalumab to ci..:

Rimini, M. ; Persano, M. ; Fornaro, L....
Immuno-Oncology and Technology. 20 (2023) - p. 100565 , 2023

Link: https://doi.org/10.1016/..

5

88P Adverse events (AEs) as potential predictive factors of..:

Persano, M. ; Rimini, M. ; Tada, T....
Immuno-Oncology and Technology. 20 (2023) - p. 100560 , 2023

Link: https://doi.org/10.1016/..

6

Encorafenib plus cetuximab with or without binimetinib in p..:

Boccaccino, A. ; Borelli, B. ; Intini, R....
ESMO Open. 7 (2022) 3 - p. 100506 , 2022

Link: https://doi.org/10.1016/..

7

111P Identification of atezolizumab plus bevacizumab progno..:

Persano, M. ; Rimini, M. ; Cascinu, S...
Immuno-Oncology and Technology. 16 (2022) - p. 100215 , 2022

Link: https://doi.org/10.1016/..

8

67P Real-world data for atezolizumab plus bevacizumab in un..:

Persano, M. ; Rimini, M. ; Tada, T....
Immuno-Oncology and Technology. 16 (2022) - p. 100172 , 2022

Link: https://doi.org/10.1016/..

9

78P Clinical outcomes with atezolizumab plus bevacizumab (A..:

Persano, M. ; Rimini, M. ; Cascinu, S...
Immuno-Oncology and Technology. 16 (2022) - p. 100182 , 2022

Link: https://doi.org/10.1016/..

10

108P Role of the prognostic nutritional index in predicting..:

Persano, M. ; Rimini, M. ; Cascinu, S...
Immuno-Oncology and Technology. 16 (2022) - p. 100212 , 2022

Link: https://doi.org/10.1016/..

11

65P Atezolizumab plus bevacizumab versus lenvatinib for unr..:

Rimini, M. ; Casadei Gardini, A. ; Persano, M....
Immuno-Oncology and Technology. 16 (2022) - p. 100170 , 2022

Link: https://doi.org/10.1016/..

12

Estrogens as Antioxidant Modulators in Human Fertility:

Mancini, A. ; Raimondo, S. ; Persano, M....
International Journal of Endocrinology. 2013 (2013) - p. 1-6 , 2013

Link: https://doi.org/10.1155/..

13

Finite Local Models for the GHZ Experiment:

Garola, C. ; Persano, M. ; Pykacz, J..
International Journal of Theoretical Physics. 53 (2013) 2 - p. 622-644 , 2013

Link: https://doi.org/10.1007/..

14

Risk maps: theoretical concepts and techniques:

Besio, M ; Ramella, A ; Bobbe, A...
Journal of Hazardous Materials. 61 (1998) 1-3 - p. 299-304 , 1998

Link: https://doi.org/10.1016/..

15

Pathologic response and survival after neoadjuvant chemothe..:

Fabbri A ; Nelli F ; Botticelli A...
info:eu-repo/semantics/altIdentifier/pmid/37441419. , 2023

Link: https://hdl.handle.net/1..